Carcinoma initiation via RB tumor suppressor inactivation: a versatile approach to epithelial subtype-dependent cancer initiation in diverse tissues.

Carcinomas arise in a complex microenvironment consisting of multiple distinct epithelial lineages surrounded by a variety of stromal cell types. Understanding cancer etiologies requires evaluating the relationship among cell types during disease initiation and through progression. Genetically engin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yurong Song, Debra Gilbert, T Norene O'Sullivan, Chunyu Yang, Wenqi Pan, Alisan Fathalizadeh, Lucy Lu, Diana C Haines, Philip L Martin, Terry Van Dyke
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/f8f8cf11eed944918839ab4509abf069
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f8f8cf11eed944918839ab4509abf069
record_format dspace
spelling oai:doaj.org-article:f8f8cf11eed944918839ab4509abf0692021-11-18T08:44:01ZCarcinoma initiation via RB tumor suppressor inactivation: a versatile approach to epithelial subtype-dependent cancer initiation in diverse tissues.1932-620310.1371/journal.pone.0080459https://doaj.org/article/f8f8cf11eed944918839ab4509abf0692013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24312475/?tool=EBIhttps://doaj.org/toc/1932-6203Carcinomas arise in a complex microenvironment consisting of multiple distinct epithelial lineages surrounded by a variety of stromal cell types. Understanding cancer etiologies requires evaluating the relationship among cell types during disease initiation and through progression. Genetically engineered mouse (GEM) models facilitate the prospective examination of early oncogenic events, which is not possible in humans. Since most solid tumors harbor aberrations in the RB network, we developed an inducible GEM approach for the establishment and assessment of carcinoma initiation in a diverse range of epithelial tissues and subtypes upon inactivation of RB-mediated tumor suppression (RB-TS). The system allows independent assessment of epithelial subtypes that express either cytokeratins (K) 18 or 19. By Cre-dependent expression of a protein that dominantly inactivates RB and functionally redundant proteins p107 and p130, neoplasia could be initiated in either K18 or K19 expressing cells of numerous tissues. By design, because only a single pathway aberration was engineered, carcinomas developed stochastically only after long latency. Hence, this system, which allows for directed cell type-specific carcinoma initiation, facilitates further definition of events that can progress neoplasms to aggressive cancers via engineered, carcinogen-induced and/or spontaneous evolution.Yurong SongDebra GilbertT Norene O'SullivanChunyu YangWenqi PanAlisan FathalizadehLucy LuDiana C HainesPhilip L MartinTerry Van DykePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 12, p e80459 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yurong Song
Debra Gilbert
T Norene O'Sullivan
Chunyu Yang
Wenqi Pan
Alisan Fathalizadeh
Lucy Lu
Diana C Haines
Philip L Martin
Terry Van Dyke
Carcinoma initiation via RB tumor suppressor inactivation: a versatile approach to epithelial subtype-dependent cancer initiation in diverse tissues.
description Carcinomas arise in a complex microenvironment consisting of multiple distinct epithelial lineages surrounded by a variety of stromal cell types. Understanding cancer etiologies requires evaluating the relationship among cell types during disease initiation and through progression. Genetically engineered mouse (GEM) models facilitate the prospective examination of early oncogenic events, which is not possible in humans. Since most solid tumors harbor aberrations in the RB network, we developed an inducible GEM approach for the establishment and assessment of carcinoma initiation in a diverse range of epithelial tissues and subtypes upon inactivation of RB-mediated tumor suppression (RB-TS). The system allows independent assessment of epithelial subtypes that express either cytokeratins (K) 18 or 19. By Cre-dependent expression of a protein that dominantly inactivates RB and functionally redundant proteins p107 and p130, neoplasia could be initiated in either K18 or K19 expressing cells of numerous tissues. By design, because only a single pathway aberration was engineered, carcinomas developed stochastically only after long latency. Hence, this system, which allows for directed cell type-specific carcinoma initiation, facilitates further definition of events that can progress neoplasms to aggressive cancers via engineered, carcinogen-induced and/or spontaneous evolution.
format article
author Yurong Song
Debra Gilbert
T Norene O'Sullivan
Chunyu Yang
Wenqi Pan
Alisan Fathalizadeh
Lucy Lu
Diana C Haines
Philip L Martin
Terry Van Dyke
author_facet Yurong Song
Debra Gilbert
T Norene O'Sullivan
Chunyu Yang
Wenqi Pan
Alisan Fathalizadeh
Lucy Lu
Diana C Haines
Philip L Martin
Terry Van Dyke
author_sort Yurong Song
title Carcinoma initiation via RB tumor suppressor inactivation: a versatile approach to epithelial subtype-dependent cancer initiation in diverse tissues.
title_short Carcinoma initiation via RB tumor suppressor inactivation: a versatile approach to epithelial subtype-dependent cancer initiation in diverse tissues.
title_full Carcinoma initiation via RB tumor suppressor inactivation: a versatile approach to epithelial subtype-dependent cancer initiation in diverse tissues.
title_fullStr Carcinoma initiation via RB tumor suppressor inactivation: a versatile approach to epithelial subtype-dependent cancer initiation in diverse tissues.
title_full_unstemmed Carcinoma initiation via RB tumor suppressor inactivation: a versatile approach to epithelial subtype-dependent cancer initiation in diverse tissues.
title_sort carcinoma initiation via rb tumor suppressor inactivation: a versatile approach to epithelial subtype-dependent cancer initiation in diverse tissues.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/f8f8cf11eed944918839ab4509abf069
work_keys_str_mv AT yurongsong carcinomainitiationviarbtumorsuppressorinactivationaversatileapproachtoepithelialsubtypedependentcancerinitiationindiversetissues
AT debragilbert carcinomainitiationviarbtumorsuppressorinactivationaversatileapproachtoepithelialsubtypedependentcancerinitiationindiversetissues
AT tnoreneosullivan carcinomainitiationviarbtumorsuppressorinactivationaversatileapproachtoepithelialsubtypedependentcancerinitiationindiversetissues
AT chunyuyang carcinomainitiationviarbtumorsuppressorinactivationaversatileapproachtoepithelialsubtypedependentcancerinitiationindiversetissues
AT wenqipan carcinomainitiationviarbtumorsuppressorinactivationaversatileapproachtoepithelialsubtypedependentcancerinitiationindiversetissues
AT alisanfathalizadeh carcinomainitiationviarbtumorsuppressorinactivationaversatileapproachtoepithelialsubtypedependentcancerinitiationindiversetissues
AT lucylu carcinomainitiationviarbtumorsuppressorinactivationaversatileapproachtoepithelialsubtypedependentcancerinitiationindiversetissues
AT dianachaines carcinomainitiationviarbtumorsuppressorinactivationaversatileapproachtoepithelialsubtypedependentcancerinitiationindiversetissues
AT philiplmartin carcinomainitiationviarbtumorsuppressorinactivationaversatileapproachtoepithelialsubtypedependentcancerinitiationindiversetissues
AT terryvandyke carcinomainitiationviarbtumorsuppressorinactivationaversatileapproachtoepithelialsubtypedependentcancerinitiationindiversetissues
_version_ 1718421421058686976